Susquehanna International Group’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $564K | Sell |
47,304
-134,032
| -74% | -$1.92M | ﹤0.01% | 9357 |
|
|
2025
Q4 | $2.8M | Sell |
181,336
-145,294
| -44% | -$2.67M | ﹤0.01% | 4996 |
|
|
2025
Q3 | $7.07M | Sell |
326,630
-126,398
| -28% | -$2.82M | ﹤0.01% | 3549 |
|
|
2025
Q2 | $10.1M | Buy |
453,028
+217,950
| +93% | +$4.84M | ﹤0.01% | 2820 |
|
|
2025
Q1 | $5.58M | Sell |
235,078
-134,479
| -36% | -$3.18M | ﹤0.01% | 3450 |
|
|
2024
Q4 | $7.82M | Sell |
369,557
-39,119
| -10% | -$1.03M | ﹤0.01% | 2958 |
|
|
2024
Q3 | $13.2M | Sell |
408,676
-145,213
| -26% | -$4.29M | ﹤0.01% | 2268 |
|
|
2024
Q2 | $13.2M | Sell |
553,889
-57,048
| -9% | -$1.46M | ﹤0.01% | 2160 |
|
|
2024
Q1 | $18.2M | Buy |
610,937
+145,947
| +31% | +$4.57M | ﹤0.01% | 1887 |
|
|
2023
Q4 | $14.9M | Sell |
464,990
-70,285
| -13% | -$2.04M | ﹤0.01% | 2134 |
|
|
2023
Q3 | $15.7M | Buy |
535,275
+29,613
| +6% | +$1.06M | ﹤0.01% | 2032 |
|
|
2023
Q2 | $22.7M | Buy |
505,662
+147,410
| +41% | +$5.63M | ﹤0.01% | 1605 |
|
|
2023
Q1 | $12.3M | Buy |
+358,252
| New | +$11.6M | ﹤0.01% | 2201 |
|
|
2022
Q4 | – | Sell |
-13,432
| Closed | -$356K | – | 13556 |
|
|
2022
Q3 | $314K | Buy |
13,432
+744
| +6% | +$23.8K | ﹤0.01% | 9686 |
|
|
2022
Q2 | $367K | Buy |
+12,688
| New | +$554K | ﹤0.01% | 9012 |
|
|
2022
Q1 | – | Sell |
-10,006
| Closed | -$495K | – | 13873 |
|
|
2021
Q4 | $534K | Buy |
10,006
+2,813
| +39% | +$130K | ﹤0.01% | 9013 |
|
|
2021
Q3 | $305K | Sell |
7,193
-11,494
| -62% | -$587K | ﹤0.01% | 10571 |
|
|
2021
Q2 | $1.25M | Sell |
18,687
-12,771
| -41% | -$693K | ﹤0.01% | 7141 |
|
|
2021
Q1 | $1.39M | Buy |
+31,458
| New | +$1.17M | ﹤0.01% | 6857 |
|
|
2020
Q3 | – | Sell |
-16,232
| Closed | -$289K | – | 11083 |
|
|
2020
Q2 | $188K | Buy |
16,232
+4,845
| +43% | +$53.1K | ﹤0.01% | 9093 |
|
|
2020
Q1 | $74K | Buy |
+11,387
| New | +$162K | ﹤0.01% | 9489 |
|
|
2019
Q4 | – | Sell |
-12,826
| Closed | -$145K | – | 10531 |
|
|
2019
Q3 | $95K | Sell |
12,826
-6,002
| -32% | -$43K | ﹤0.01% | 9584 |
|
|
2019
Q2 | $153K | Buy |
+18,828
| New | +$188K | ﹤0.01% | 9353 |
|
|
2018
Q3 | – | Sell |
-10,846
| Closed | -$173K | – | 10127 |
|
|
2018
Q2 | $162K | Buy |
+10,846
| New | +$182K | ﹤0.01% | 8799 |
|
|
2017
Q1 | – | Sell |
-19,826
| Closed | -$385K | – | 9847 |
|
|
2016
Q4 | $314K | Sell |
19,826
-7,058
| -26% | -$117K | ﹤0.01% | 7895 |
|
|
2016
Q3 | $544K | Buy |
+26,884
| New | +$494K | ﹤0.01% | 5916 |
|
|
2016
Q2 | – | Sell |
-13,331
| Closed | -$198K | – | 9237 |
|
|
2016
Q1 | $177K | Sell |
13,331
-36,182
| -73% | -$559K | ﹤0.01% | 8074 |
|
|
2015
Q4 | $1.01M | Buy |
+49,513
| New | +$946K | ﹤0.01% | 5370 |
|
Other funds holding SGRY
BCI
PCM
KSCM
VPM
VCM
Susquehanna International Group's SGRY Position: Q1 2026 in Review
Susquehanna International Group reduced its Surgery Partners (SGRY) stake by 74% in Q1 2026, selling an estimated $1.92M and leaving 47,304 shares worth $564K. The position accounts for ﹤0.01% of the portfolio, ranked #9357.
Susquehanna International Group first reported a position in SGRY in Q4 2015 and has held it in 28 quarters since. The position peaked at $22.7M in Q2 2023. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.
- Susquehanna International Group held 47,304 shares of Surgery Partners worth $564K as of Q1 2026.
- Susquehanna International Group sold 134,032 Surgery Partners shares in Q1 2026, an estimated $1.92M.
- Surgery Partners made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9357 holding.
- Susquehanna International Group first reported a position in Surgery Partners in Q4 2015 and has held it in 28 quarters since.
- Susquehanna International Group's Surgery Partners position peaked at $22.7M in Q2 2023.
- 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.